Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at ...

Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...

Melanoma might sound rare, as it accounts for 1% of skin cancer diagnoses; but those diagnoses are serious because data published by the National Library of Medicine notes that melanoma causes 75% of ...

Melanoma in situ (MIS), also called stage 0 melanoma, is the earliest stage of melanoma, when the cancer is confined to the outermost layer of skin. Most melanomas affect the skin, but they can also ...